
Maxim Sevostyanov
Director of Global Regulatory and Medical Translations
Education:
2015—2019 — Manash Kozybayev
North Kazakhstan University

gaukhar bilimbayeva
Chief Executive Officer (CEO), PharmD, MBA
Education:
1997—2002 — S. Asfendiyarov Kazakh National Medical University
2016—2018 — MBA, Swiss Business School, Zurich, Switzerland

dauren bilimbayev
Founder
Education:
2000—2004 — T. Ryskulov Kazakh Economic University
2003—2005 — S. Amanzholov East Kazakhstan State University
2016—2017 — NIMA International Marketing School, the Netherlands

Anna polivoda
Deputy CEO, Head
of Sales and Marketing
Education:
2018—2022 — Almaty Management University (AlmaU)
2022—2024 — Sh. Murtaza International University

gulzhan akhmetova
Head of Registration Department,
Quality Responsible Person
Education:
2005—2009 — Al-Farabi Kazakh National University
2013—2015 — K. I. Satpayev Kazakh National Technical University (KazNTU)

Bulegenova Zhadyra
Senior Registration Specialist
Education:
2008-2012 — Al-Farabi Kazakh National University (Bachelor's)
2012-2014 — S. Asfendiyarov Kazakh National Medical University (Master's)

Jenis Kamila
Registration Specialist
Education:
2016-2020 — S. Asfendiyarov Kazakh National Medical University

Asel Seidakhmetova
Senior Registration Specialist
Education:
2006-2010 — Kazakh National Agrarian University (KazNAU)





















Up to 14 days are allowed for submission and up to 210 calendar days for examination and registration, excluding clock-stops. Including clock-stops, the timeline depends on the number and complexity of the experts' deficiency letters.
Yes, for a number of products registered in countries with stringent regulatory authorities, the legislation provides for an accelerated procedure. Whether it is suitable for your product can be clarified at a free consultation.
The examination includes a preliminary examination (verification of the completeness of the dossier), a specialized examination (assessment of quality, efficacy and safety) and, where necessary, laboratory testing of samples.
The dossier is compiled in CTD format. The instructions for medical use and the labeling text are translated into Ukrainian, and the quality control methods are developed in accordance with the requirements of the State Pharmacopoeia of Ukraine.
Based on a positive expert conclusion, the Authority decides on state registration, and the product data are entered in the State Register of Medicinal Products of Ukraine.